Published 1 year ago

Indivior PLC to Acquire Opiant Pharmaceuticals - Opiant Pharma (NASDAQ:OPNT)

Summary by Ground News

Indivior (OTCPK:INVVY) is acquiring opioid overdose therapy maker Opiant Pharmaceuticals (NASDAQ:OPNT) for ~$145M. Indivior will acquire all outstanding shares of Opiant for an upfront $20 per share in cash. Opiant contributed to the development of the formulation of Narcan Nasal Spray.

0 Articles

All

Left

Center

Right

Benzinga

Indivior PLC to Acquire Opiant Pharmaceuticals - Opiant Pharma (NASDAQ:OPNT)

Indivior to acquire Opiant Pharmaceuticals for total consideration of $28.00 per share comprising of an upfront cash payment of $20.00 per share at closing plus contingent value rights (CVRs) worth up to $8.00 per share in cash, payable on achievement of certain net revenue thresholds for OPNT003Upfront payment represents a 111% premium to Opiant's closing share price of November 11, 2022, and 99% premium to Opiant's 30-day volume-weighted avera…

1 year ago·New York, United States

Read Full Article

PR Newswire

Indivior To Acquire Opiant Pharmaceuticals

/PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") and Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) ("Opiant") today announced that the...

1 year ago·United States

Read Full Article

Globe Newswire

Indivior PLC to Acquire Opiant Pharmaceuticals

Indivior to acquire Opiant Pharmaceuticals for total consideration of $28.00 per share comprising of an upfront cash payment of $20.00 per share at closing...

1 year ago

Read Full Article